Search

Your search keyword '"Utsunomiya, Atae"' showing total 1,138 results

Search Constraints

Start Over You searched for: Author "Utsunomiya, Atae" Remove constraint Author: "Utsunomiya, Atae"
1,138 results on '"Utsunomiya, Atae"'

Search Results

2. Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers

3. Clinical landscape of TP73 structural variants in ATL patients

6. Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national survey

7. Cord blood is a suitable donor source of allogeneic hematopoietic cell transplantation for adult T-cell leukemia-lymphoma: a nationwide retrospective study

8. An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma

9. A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan

11. Whole-genome landscape of adult T-cell leukemia/lymphoma

12. Intragenic silencer regulates human retrovirus latency by recruiting RUNX1

14. Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study

16. Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCT

17. Individual HLAs affect survival after allogeneic stem cell transplantation in adult T‐cell leukaemia/lymphoma.

18. Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study

20. Performance evaluation of Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test for different diagnostic situations

21. Anti‐HTLV‐1 immunity combined with proviral load as predictive biomarkers for adult T‐cell leukemia‐lymphoma

22. MO48-5 Progression of disease within 5 months of adult T-cell leukemia-lymphoma (ATL5) as a clinical endpoint for high-risk mortality outcomes

23. Author Correction: 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy

26. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial

29. Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation

30. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma

35. HTLV-1 infection promotes excessive T cell activation and transformation into adult T cell leukemia/lymphoma

37. Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan

38. Anti‐HTLV‐1 immunity combined with proviral load as predictive biomarkers for adult T‐cell leukemia‐lymphoma.

40. Table S2 from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1

41. Supplementary Data from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1

42. Data from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1

45. Data from Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma

46. Supplementary Figure 1, Tables S1-6 from Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma

50. Supplementary Data from Molecular Characterization of Chronic-type Adult T-cell Leukemia/Lymphoma

Catalog

Books, media, physical & digital resources